Entrada Therapeutics Inc TRDA 深 滬
等待開盤 06-25 09:30:00 美东时间
7.54
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 7.54
- 總市值 2.93亿
- 52周最高 16.45
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.93
- 委 比 0.00%
- 總股本 3882.06万
- 歷史最高 36.85
- 量 比 0
- 振 幅 0.00%
- 歷史最低 4.93
- 每 手 1
- 風險率 2.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
Entrada Advances Duchenne Muscular Dystrophy Drug to Higher Dose Cohort, Safety Review Clears Next Stage of Clinical Trial
Entrada Therapeutics, Inc. (NASDAQ:TRDA) today announced that an independent Data Monitoring Committee (DMC), per study protocol, has reviewed all available safety and PK data from the eight participants enrolled in
06-02 19:17
HC Wainwright & Co. Downgrades Entrada Therapeutics to Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Entrada Therapeutics (NASDAQ:TRDA) from Buy to Neutral.
05-08 19:57
Dow Dips 350 Points; US Foods Posts Downbeat Earnings
Dow falls over 100 points, S&P 500 and NASDAQ also down. Tech sector up, energy stocks down. US Foods reports lower Q1 earnings and sales. Agilon Health, Aaon, and Rackspace Technology see gains while Entrada, Fastly, and enGene Therapeutics decline. Euro zone and Asian markets mixed.
05-08 01:39
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Agilon Health (NYSE:AGL) shares moved upwards by 115.7% to $60.08 duri...
05-08 01:05
Entrada Therapeutics shares are trading lower after the company reported mixed Q1 financial results.
Entrada Therapeutics shares are trading lower after the company reported mixed ...
05-07 20:46
Entrada posts strong ENTR-601-44 Duchenne Phase 1/2 data
Entrada Therapeutics Inc ( ($TRDA) ) has issued an announcement. On May 7, 2026...
05-07 19:55
Entrada Therapeutics Q1 EPS $(0.95) Beats $(1.09) Estimate, Sales $875.000K Miss $1.393M Estimate
Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.09) by 12.84 percent. This is a 126.19 percent decrease over losses of $(0.42) per share
05-07 19:21
Entrada Therapeutics announces annual shareholder meeting
Entrada Therapeutics announces annual shareholder meeting Entrada Therapeutics scheduled 2026 annual stockholder meeting for June 10, 2026, to be held virtually. Vote set for election of 2 Class II directors for terms running to 2029. Shareholders to consider ratification of Ernst & Young as indepen
04-24 20:31
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
